Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Propafenone: a novel type Ic antiarrhythmic agent.

R B Parker1, P L McCollam, J L Bauman

  • 1Department of Pharmacy Practice, University of Illinois, Chicago 60612.

DICP : the Annals of Pharmacotherapy
|March 1, 1989
PubMed
Summary

Propafenone, a type Ic anti-arrhythmic, effectively treats supraventricular tachycardias but may be less effective for sustained ventricular arrhythmias. Further studies are needed to compare it with other type Ic agents.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Health Care Utilization and Costs After Warfarin Discontinuation Among Patients with Non-Valvular Atrial Fibrillation.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Discontinuation/Interruption of Warfarin Therapy in Patients with Non-Valvular Atrial Fibrillation.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

A pharmacodynamic model of the effects of controlled-onset extended-release verapamil on 24-hour ambulatory blood pressure.

International journal of clinical pharmacology and therapeutics·2005
Same author

Impact of the cost of prescription drugs on clinical outcomes in indigent patients with heart disease.

Pharmacotherapy·2002
Same author

Repair of diaphyseal femoral fractures in cats using interlocking intramedullary nails: 12 cases (1996-2000).

Journal of the American Veterinary Medical Association·2001

Area of Science:

  • Pharmacology
  • Cardiology
  • Electrophysiology

Background:

  • Propafenone is an investigational anti-arrhythmic drug.
  • It exhibits type Ic, weak beta-, and calcium-channel blocking properties.
  • Its bioavailability is dose-dependent, and hepatic metabolism is polymorphic.

Purpose of the Study:

  • To review the efficacy and adverse effects of propafenone.
  • To discuss its role in treating various cardiac arrhythmias.
  • To highlight the need for comparative studies.

Main Methods:

  • Literature review of propafenone's pharmacological properties.
  • Analysis of clinical data on its efficacy in different arrhythmia types.
  • Evaluation of reported adverse reactions.

Related Experiment Videos

Main Results:

  • Propafenone effectively suppresses spontaneous ventricular ectopy.
  • It is useful in treating supraventricular tachycardias, including AV nodal reentrant tachycardia, AV reentrant tachycardia with Wolff-Parkinson-White syndrome, and atrial fibrillation.
  • The drug may be less effective in sustained ventricular tachycardia or fibrillation.

Conclusions:

  • Propafenone is a viable option for certain supraventricular tachycardias.
  • Its efficacy in sustained ventricular arrhythmias requires further investigation.
  • Comparative studies are essential to establish its therapeutic position among type Ic agents.